AstraZeneca aims for two new drugs every year
8th Sep 2005, 18:15 GMT
LONDON (Reuters) - AstraZeneca Plc AZN.L, recovering from a series of setbacks to its late-stage drug pipeline, said on Thursday it believed its research labs had long-term potential to produce two new medicines every year.
Latest news from Reuters: Business:
- BA ups stakes in bed wars
- AMEC spurns bid approach from private equity team
- Resolution eyes options for future
- Stricter savings-club rules seen after Farepak
- Airbus to outsource 1.84 bln pounds of new work
- Supermarkets rapped on food packaging
- British defence ministry seeks delay in KBR IPO
- Dell buys ACS to expand UK technology consulting
- Anglo American eyes China coal-to-energy project
- Barrick in approach for European Goldfields - paper